Yes, several novel therapies are being investigated to address resistance. CAR-T cell therapy is showing promise, particularly in hematologic cancers. Bispecific antibodies and cancer vaccines are also emerging as potential strategies. Additionally, epigenetic therapies are being explored to tackle resistance by modifying gene expression.
